CVE-2023-31167

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

Description

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows Relative Path Traversal. SEL acSELerator Bay Screen Builder software is distributed by SEL-5033 SEL acSELerator RTAC, SEL-5030 Quickset, and SEL Compass. CVE-2023-31167 and was patched in the acSELerator Bay Screen Builder release available on 20230602. Please contact SEL for additional details. This issue affects SEL-5036 acSELerator Bay Screen Builder Software: before 1.0.49152.778.

Category

5.0
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.10%
Vendor Advisory selinc.com
Affected: Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-31167?
CVE-2023-31167 has been scored as a medium severity vulnerability.
How to fix CVE-2023-31167?
To fix CVE-2023-31167, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-31167 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-31167 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-31167?
CVE-2023-31167 affects Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.